2,105
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Reevaluating Chronic Opioid Monitoring During and After The COVID-19 Pandemic

, ORCID Icon, , &
Pages 353-358 | Received 08 Aug 2020, Accepted 19 Aug 2020, Published online: 18 Sep 2020
 

Financial & competing interests disclosure

N Mehta is a consultant for Nevro, Salix pharma, Biodelivery Sciences and has contracted research with Nevro and Abbott. A Gulati is a Medical advisor for AIS and a consultant for Medtronic, SPR therapeutics, Nalu Medical, Bausch Health and Flowonix. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.